MNDY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
MNDY is not a strong buy right now for a beginner long-term investor, despite decent fundamentals and a generally constructive analyst backdrop. The stock is trading near $87.79 pre-market with only a small gain, technicals are mixed rather than strongly bullish, and there is no strong proprietary buy signal today. For an impatient investor, this is not an attractive immediate entry based on the current data.
The technical picture is neutral to slightly positive. MACD histogram is above zero at 1.178, but it is contracting, which weakens momentum. RSI_6 at 59.457 is neutral, suggesting neither overbought nor oversold conditions. Moving averages are converging, which points to consolidation rather than a clear trend. Price is above the pivot level of 84.764 and below resistance at 93.664, so the stock is in the middle of its near-term range. The short-pattern estimate suggests mixed performance, with a possible small near-term bounce over the next week/month, but not a high-conviction breakout setup.
["Several analysts highlighted a beat-and-raise Q1 report.", "BTIG and Canaccord pointed to strong revenue beat, seat growth, and improving AI contribution.", "TD Cowen and Barclays noted stability in growth execution and upmarket momentum.", "AI is increasingly described as a real growth contributor rather than just a narrative.", "Pre-market price is slightly positive."]
["No fresh news in the last week, so there is no near-term event-driven catalyst.", "UBS cut its target to $85 and kept Neutral, signaling limited upside in the near term.", "Jefferies keeps Hold and cited AI disruption fears and current pressure.", "Some analysts trimmed price targets broadly after earnings, showing tempered expectations.", "Hedge funds and insiders are both neutral with no notable recent buying activity.", "No congress trading data or influential figure activity to support a bullish case."]
Latest quarter data was not provided in structured financials, but analyst commentary on the most recent quarter was strong. The company posted a record Q1 revenue beat, a beat-and-raise result, and stronger growth execution. Commentary also highlighted growing seats, improving monetization, and early AI contribution. The latest quarter season mentioned in the data is Q1. Overall, the latest quarter appears healthy and growing, but forward-looking uncertainty is still limiting upside.
Analyst sentiment is mixed but mildly positive overall. Bulls include BTIG, TD Cowen, Barclays, Citi, Canaccord, and Oppenheimer, all maintaining Buy/Overweight/Outperform views, though many lowered price targets. Bears/neutral views include UBS at Neutral, Jefferies at Hold, and Piper Sandler at Neutral. The recent trend shows a beat-and-raise quarter, but price targets were frequently cut, indicating analysts respect the fundamentals yet have become more cautious on valuation and forward guidance. Wall Street’s pros see improving growth, AI tailwinds, and better execution; the cons side focuses on uncertain fiscal 2026 upside, software multiple compression, and ongoing AI disruption concerns.
